Marcelino Bernardo
National Institutes of Health, National Institutes of Health Clinical Center
Papers
4
Total Citations
365
H-Index
4
About
Marcelino Bernardo is a leading figure in the advancement of prostate cancer imaging and intervention, with a career defined by the integration of cutting-edge radiology and robotics. His primary research focuses on improving the detection and targeted treatment of localized prostate cancer. A major contribution is his pioneering work comparing endorectal coil and nonendorectal coil MRI at 3 Tesla, demonstrating that high-quality, non-invasive scans can effectively localize cancer—a finding supported by his highly cited 2013 study (155 citations). He has also been instrumental in evaluating novel molecular imaging, such as ¹⁸F FACBC PET/CT, for its ability to distinguish cancerous tissue from benign prostatic hyperplasia (147 citations). Beyond diagnostics, Bernardo is a key innovator in interventional radiology, having co-developed a pneumatically-actuated, MRI-conditional robotic system for focal laser ablation. This computer-assisted platform represents a significant leap toward precise, minimally invasive treatment, offering patients a targeted alternative to radical therapies and reducing side effects like impotence. His work bridges imaging science and therapeutic robotics, positioning him at the forefront of personalized prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Robotic System for MRI-Guided Focal Laser Ablation in the Prostate58 citations · 2016
- 4